Menu Menu

TEVA    Teva Pharmaceutical Industries Ltd    818686    
Income Statement
Revenue 16,544,000,000
Net Income -1,639,000,000
Profit Margin -9.91%

Balance Sheet
Current Assets 12,552,000,000
Assets 39,326,000,000
Current Liabilities 12,796,000,000
Liabilities 33,946,000,000
Equity 5,380,000,000
Shares Out 1,132,992,000

Cash Flow Statement
Operating Cash Flow 1,247,000,000
Investing Cash Flow 792,000,000

Market Analysis
Market Cap 19,852,335,430
Price 16.36
BVPS 4.75
PB 3.42
EPS -0.42
PS 0.30
FCF 2,039,000,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
1/31 1.00 2/5 -1.45
Apr May Jun
5/08 0.48
Jul Aug Sep
7/31 0.61
Oct Nov Dec
11/06

Find a discrepancy? The most accurate way to find company fundamental data is to view TEVA documents filed with the SEC.


TEVA Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: